tiprankstipranks
Advertisement
Advertisement
Castle Biosciences price target raised to $57 from $52 at Lake Street
PremiumThe FlyCastle Biosciences price target raised to $57 from $52 at Lake Street
1M ago
Castle Biosciences price target lowered to $36 from $43 at Baird
Premium
The Fly
Castle Biosciences price target lowered to $36 from $43 at Baird
1M ago
Castle Biosciences Lifts 2026 Outlook After Q2 Growth
Premium
Company Announcements
Castle Biosciences Lifts 2026 Outlook After Q2 Growth
1M ago
Castle Biosciences initiated with a Buy at Roth Capital
PremiumThe FlyCastle Biosciences initiated with a Buy at Roth Capital
2M ago
Castle Biosciences’ TissueCypher Test surpasses 100,000 orders
Premium
The Fly
Castle Biosciences’ TissueCypher Test surpasses 100,000 orders
3M ago
Castle Biosciences Explores Early Atopic Dermatitis Flare Detection With Home Device Study
Premium
Company Announcements
Castle Biosciences Explores Early Atopic Dermatitis Flare Detection With Home Device Study
3M ago
Castle Biosciences Lifts 2026 Guidance Amid Test Surge
PremiumCompany AnnouncementsCastle Biosciences Lifts 2026 Guidance Amid Test Surge
4M ago
Carlisle price target lowered to $43 from $44 at Baird
Premium
The Fly
Carlisle price target lowered to $43 from $44 at Baird
4M ago
Castle Biosciences: Buy Rating Reiterated as Strong Q1, Raised 2026 Outlook and Unchanged $40 Price Target Underscore Undervaluation
Premium
Ratings
Castle Biosciences: Buy Rating Reiterated as Strong Q1, Raised 2026 Outlook and Unchanged $40 Price Target Underscore Undervaluation
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100